If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,164.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.344%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,164.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Apr 2023 17:15

RNS Number : 2788X
Savills PLC
24 April 2023
 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)

 

Vesting of Share Awards

 

On 21 April 2023, ordinary shares of the Company have been allotted to Directors and PDMRs of the Company as follows in satisfaction of the partial vesting of Awards made on 16 April 2018 under The Savills plc Performance Share Plan (the "Performance Share Plan"):-

 

Director / PDMR

Number of Shares Transferred

Number of Shares Disposed

Shareholding following this notification

Shareholding as a % of issued share capital

Mark Ridley (Director)

11,173

11,173

231,854 

0.16

Simon Shaw (Director)

11,758

11,758

182,579

0.13

Chris Lee (PDMR)

5,985

5,985

119,000

0.08

 

The share price on disposal of all shares was £9.766 per share.

 

The balance of the Awards made on 16 April 2018 have lapsed.

 

 

Grant of Share Awards

 

The Company announces that on 21 April 2023 awards have been made under to Directors and PDMRs of the Company as follows under the Performance Share Plan:

 

Director / PDMR

Number of Shares subject to the Performance Share Plan awarded to the Director / PDMR on 21 April 2023

Total number of shares subject to the Performance Share Plan following this notification

Mark Ridley (Director)

65,336

234,751

Simon Shaw (Director)

50,000

179,497

Chris Lee (PDMR)

25,288

91,116

 

The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.

Awards of shares are made subject to a three-year performance period. Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period.

Awards vest subject to the satisfaction of the following performance criteria measured over the three years to 31 December 2025:

(a) one-third of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);

(b) a further one-third of the initial value of an award is subject to Group Earnings per Share ('EPS') performance; and

(c) the final one-third of the initial value of an award is subject to the three-year average Return on Capital Employed ('ROCE') of the Company.

Awards vest as follows:

(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound or more with sliding scale vesting between the two points;

(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's EPS growth over the period is 4% p.a., compound rising to 100% (i.e. maximum) if the Company's EPS growth over the period is 10% p.a., compound or more with sliding scale vesting between the two points; and

(c) for the ROCE linked part of an award, 25% (i.e. threshold) will vest if the Company's ROCE is at least 12% p.a., rising to 100% (i.e. maximum) if the Company's ROCE is 22% p.a. or more; and with straight-line vesting between the two points.

 

The Company announces that on 21 April 2023 the grant of the share based element of 2022 profit share awards has been made under the Savills Deferred Share Bonus Plan to Directors and PDMRs as follows:-

 

Director/ PDMR

Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the Director/ PDMR on 21 April 2023

Mark Ridley (Director)

108,981

Simon Shaw (Director)

83,876

Alex Jeffrey (PDMR)

40,966

Chris Lee (PDMR)

16,806

Raymond Lee (PDMR)

32,432

David Lipson (PDMR)

9,309

Christian Mancini (PDMR)

27,037

Mitchell Rudin (PDMR)

9,309

James Sparrow (PDMR)

73,529

 

The Company announces that on 21 April 2023 the grant of an award has been made under the Savills Deferred Share Plan to a PDMR as follows:-

 

PDMR

Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 21 April 2023

Alex Jeffrey

36,764

Vesting on a sliding scale is dependent upon the satisfaction of performance criteria relating to the financial performance of Savills Investment Management, including the performance of funds managed by Savills Investment Management, over the period 2023 to 2025.

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

 

The Company announces that on 21 April 2023 the grant of an award has been made under The Schedule to The Savills Deferred Share Plan to a PDMR based in the United States of America as follows:-

 

PDMR

Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 21 April 2023

David Lipson (PDMR)

42,318

20% of Mr Lipson's award will vest on each of the five anniversaries subsequent to the date of grant subject to continued employment. The award is subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting dates to reflect final and interim dividends declared during the Deferred Periods.

Resulting beneficial interests under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan further to the above notifications are as follows:

Director/ PDMR

Resulting beneficial interest under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan

Mark Ridley (Director)

308,398

Simon Shaw (Director)

232,772

Alex Jeffrey (PDMR)

387,042

Chris Lee (PDMR)

78,650

Raymond Lee (PDMR)

130,574

David Lipson (PDMR)

187,304

Christian Mancini (PDMR)

146,408

Mitchell Rudin (PDMR)

194,919

James Sparrow (PDMR)

165,149

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the Director/ PDMR

 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Alex Jeffrey

4. Chris Lee

5. Raymond Lee

6. David Lipson

7. Christian Mancini

8. Mitchell Rudin

9. James Sparrow

 

2.

Reason for the notification

 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Chief Executive Officer - Savills Investment Management/ PDMR

4. Group Legal Director and Company Secretary/ PDMR

5. Chief Executive - Hong Kong, Macau and Greater China/ PDMR

6. President - Savills North America/ PDMR

7. Chief Executive Officer Asia Pacific (ex-Greater China)/ PDMR

8. Chairman and CEO - Savills North America/ PDMR

9. CEO, Savills UK & EMEA/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

1) Vesting of awards under the Company's Performance Share Plan and sale of resultant shares

2) Grant of awards over Ordinary Shares in accordance with the Company's Performance Share Plan

3) Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan and Deferred Share Plan

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

1)

Acquisition

£0.025 per share

 

 

 

 

 

 

 

Disposal

£9.766 per share

1. 11,173

2. 11,758

3. n/a

4. 5,985

5. n/a

6. n/a

7. n/a

8. n/a

9. n/a

 

1. 11,173

2. 11,758

3. n/a

4. 5,985

5. n/a

6. n/a

7. n/a

8. n/a

9. n/a

 

2)

£nil per share

1. 65,336

2. 50,000

3. n/a

4. 25,288

5. n/a

6. n/a

7. n/a

8. n/a

9. n/a

 

3)

£nil per share

1. 108,981

2. 83,876

3. 77,730

4. 16,806

5. 32,432

6. 51,627

7. 27,037

8. 9,309

9. 73,529

 

(e)

Aggregated information

 

- Aggregated volume

- Price

 

N/A

 

 

(f)

Date of the transaction

 

21 April 2023

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

24 April 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGZDVDDGFZM
Date   Source Headline
20th Mar 20201:40 pmRNSDirector/PDMR Shareholding
13th Mar 20201:43 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results
11th Mar 20201:12 pmRNSDirector/PDMR Shareholding
26th Feb 202012:58 pmRNSHolding(s) in Company
17th Feb 20203:29 pmRNSBlock listing Interim Review
11th Feb 20205:00 pmRNSDirector/PDMR Shareholding
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20209:00 amRNSBlock listing Interim Review
13th Jan 202012:04 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSYear end Trading Update
7th Jan 202010:55 amRNSDirector/PDMR Shareholding
20th Dec 20191:42 pmRNSChange of External Auditor
12th Dec 20193:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20199:38 amRNSDirector/PDMR Shareholding
2nd Dec 20194:00 pmRNSTotal Voting Rights
2nd Dec 20192:27 pmRNSDirector/PDMR Shareholding
12th Nov 20193:51 pmRNSDirector/PDMR Shareholding
31st Oct 201910:50 amRNSBoard Change
14th Oct 20199:39 amRNSDirector/PDMR Shareholding
1st Oct 20199:00 amRNSTotal Voting Rights
12th Sep 20191:12 pmRNSDirector/PDMR Shareholding
10th Sep 20193:57 pmRNSDirector/PDMR Shareholding
2nd Sep 20195:04 pmRNSTotal Voting Rights
15th Aug 20193:56 pmRNSBlock listing Interim Review
13th Aug 20194:39 pmRNSDirector/PDMR Shareholding
8th Aug 20198:47 amRNSInterim Dividend Record Date Correction
8th Aug 20197:00 amRNSHalf-year Report
22nd Jul 201911:29 amRNSBlock listing Interim Review
18th Jul 20195:20 pmRNSHolding(s) in Company
11th Jul 20194:58 pmRNSDirector/PDMR Shareholding
11th Jun 20192:36 pmRNSDirector/PDMR Shareholding
3rd Jun 20197:00 amRNSTotal Voting Rights
13th May 201912:27 pmRNSDirector/PDMR Shareholding
10th May 20195:02 pmRNSDirector/PDMR Shareholding
8th May 20194:33 pmRNSResult of AGM
8th May 201910:04 amRNSAGM Statement
1st May 20197:00 amRNSTotal Voting Rights
24th Apr 20199:30 amRNSAppointment of New CEO of Savills Investment Mgmt
17th Apr 201912:00 pmRNSIssue of Equity
16th Apr 20193:24 pmRNSDirector/PDMR Shareholding
11th Apr 20194:02 pmRNSDirector/PDMR Shareholding
3rd Apr 20194:06 pmRNSHolding(s) in Company
1st Apr 201912:17 pmRNSAnnual Report and AGM Notice
22nd Mar 20192:22 pmRNSHolding(s) in Company
20th Mar 201912:11 pmRNSHolding(s) in Company
19th Mar 20194:11 pmRNSDirector/PDMR Shareholding
14th Mar 20193:13 pmRNSHolding(s) in Company
14th Mar 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.